Skip to main content
See every side of every news story
Published loading...Updated

EirGenix Inaugurates New Microbial Facility in Zhubei, Boosting Capacity to Capture Global CDMO Opportunities

Summary by GeneOnline News
EirGenix, Inc. (TWSE: 6589), a leading Taiwanese biopharmaceutical contract development and manufacturing organization (CDMO), held a grand inauguration ceremony on September 16 for its new microbial facility in Zhubei. The new facility primarily enhances production capacity for microbial protein expression and plasmid DNA (pDNA) and will boost the company’s existing microbial fermentation capacity ninefold. During the ceremony, the company also…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

GeneOnline News broke the news on Thursday, September 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal